The life sciences industry has come a long way since the last COVID-19 outbreak. Today, organizations are prioritizing efficiency, speed, and innovation. That’s why biopharma and biotech companies are increasingly broadening their investments in physical spaces. Campuses and facilities are being r
The global brain-computer interface (BCI) market is expected to grow from USD $2.1 million in 2022 to USD $9.4 million by 2032, with a growth rate of 16.7% from 2023 to 2032. This exciting area of research and development can create a direct communication link between the human brain and devices
In an era when speed, accuracy, and efficiency are critical, the biopharma industry stands on the verge of a huge transformation. Artificial intelligence (AI) is moving beyond just a mere buzzword; it is fast becoming an important factor in how drugs are discovered, developed, and marketed. The
There is no question that obesity is one of the most common healthcare problems plaguing the modern world. According to the National Health and Nutrition Examination Survey (NHANES), 42.4% of Americans suffer from obesity, while 30.7% are on their way to becoming obese. Moreover, approximately 1
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is such an innovative medicine, that it seems like something straight out of a science fiction novel. This gene editing technology allows scientists to precisely target spots in our DNA to fix mutations or stop disease-ridden parts
We haven’t stepped that deep into the 21st century, but we have already witnessed how a microscopic organism like a virus can wreak havoc. They evolve to become more resistant to our usual remedies so we have to escape them in a biological race on an atomic level. Consequently, scientists have come
